(Q35200729)

7 August 2017

1 reference

title

The economics of smoking and cardiovascular disease (English)

1 reference

7 August 2017

James Lightwood

1

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Progress in Cardiovascular Diseases

7 August 2017

published in

1 reference

7 August 2017

volume

46

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

39-78

1 reference

The economics of tobacco regulation

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Addiction as a market failure: using rational addiction results to justify tobacco regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The Economic Implications of Tobacco Product Sales in a Nontobacco State

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The economics of tobacco: myths and realities

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Medical costs of smoking in the United States: estimates, their validity, and their implications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The financial impact of smoking on health-related costs: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The most expensive medical conditions in America.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Comparing the national economic burden of five chronic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The cost of health conditions in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The emergence of cardiovascular disease during urbanisation of Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Expected gains in life expectancy from various coronary heart disease risk factor modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Long-term impact of smoking cessation on the incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Sequential and average attributable fractions as aids in the selection of preventive strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking and Alcohol Abuse: A Comparison of Their Economic Consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The economic costs of the health effects of smoking, 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking-attributable medical care costs in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Comparison of physician based reporting of tobacco attributable deaths and computer derived estimates of smoking attributable deaths, Oregon, 1989 to 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The economic impact of smoking in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Combined oral contraceptives, smoking, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Public health burden of coronary heart disease risk factors among middle-aged and elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Population attributable fraction of stroke incidence in middle-aged and elderly people: contributions of hypertension, smoking and atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Methodological issues in estimating smoking-attributable mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Estimation of the possible effect of interventive measures in the area of ischemic heart diseases by the attributable risk percentage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

On the use of a logistic risk score in predicting risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Modeling Smoking History: A Comparison of Different Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of Women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The relation between various histological types of lung cancer and the number of years since cessation of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Partitioning methods for multifactorial risk attribution

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Passive smoking and heart disease. Epidemiology, physiology, and biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Invited commentary: confounding, measurement error, and publication bias in studies of passive smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Environmental tobacco smoke, cardiovascular disease, and the nonlinear dose-response hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Childhood passive smoking, race, and coronary artery disease risk: the MCV Twin Study. Medical College of Virginia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

A prospective study of passive smoking and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Workplace exposure to passive smoking and risk of cardiovascular disease: summary of epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Platelet sensitivity to prostacyclin in smokers and non-smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Acute effects of passive smoking on the coronary circulation in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Passive smoking at work as a risk factor for coronary heart disease in Chinese women who have never smoked

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness analysis in heart disease, Part I: General principles

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Critical ratios and efficient allocation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness analysis in heart disease, Part II: Preventive therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Environmental tobacco smoke: health effects and policies to reduce exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Effect of smoke-free workplaces on smoking behaviour: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The impact of workplace smoking ordinances in California on smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

A prospective investigation of the impact of smoking bans on tobacco cessation and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Costs of employee smoking in the workplace in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Actual and perceived impacts of tobacco regulation on restaurants and firms.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The effect of ordinances requiring smoke-free restaurants and bars on revenues: a follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The effect of a smoke-free law on restaurant business in South Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Effects of smoking restrictions in the workplace

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The effectiveness of state-level tobacco control interventions: a review of program implementation and behavioral outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Trends in adult cigarette smoking in California compared with the rest of the United States, 1978-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Has the California tobacco control program reduced smoking?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The California Tobacco Control Program and potential harm reduction through reduced cigarette consumption in continuing smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Impact of the Massachusetts tobacco control programme: population based trend analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Impact of the American Stop Smoking Intervention Study on cigarette consumption

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

State youth-access tobacco control policies and youth smoking behavior in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

What Is the Potential Cost-Effectiveness of Enforcing a Prohibition on the Sale of Tobacco to Minors?1

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Has smoking cessation ceased? Expected trends in the prevalence of smoking in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

How long will today's new adolescent smoker be addicted to cigarettes?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Curtailing tobacco use among youth: evaluation of project 4-health

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Impact study of tobacco possession law enforcement in Florida.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The effect of local tobacco sales laws on adolescent smoking initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Reductions in smoking prevalence and cigarette consumption associated with mass-media campaigns

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Youth access interventions do not affect youth smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Youth access: the baby and the bath water

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Is it time to abandon youth access programmes?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Investing in youth tobacco control: a review of smoking prevention and control strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The second Chicago televised smoking cessation program: a 24-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Experts’ Agreement on the Relative Effectiveness of 29 Smoking Reduction Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Understanding the variability in the effectiveness of community heart health programs: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Getting to the truth: evaluating national tobacco countermarketing campaigns

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Evaluation of antismoking advertising campaigns

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Evidence of the dose effects of an antitobacco counteradvertising campaign

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

A mass media programme to prevent smoking among adolescents: costs and cost effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost effectiveness of a mass media-led anti-smoking campaign in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of a community anti-smoking campaign targeted at a high risk group in London

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of a school-based tobacco-use prevention program.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The cost-effectiveness of a cardiovascular risk reduction program in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The Working Healthy Project: a worksite health-promotion trial targeting physical activity, diet, and smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Health and Economic Implications of a Work-Site Smoking-Cessation Program

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking cessation in a blue-collar population: results from an evidence-based pilot program

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Worksite wellness programs: incremental comparison of screening and referral alone, health education, follow-up counseling, and plant organization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

A review of the health impact of smoking control at the workplace

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Economic implications of smoking cessation therapies: a review of economic appraisals

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of smoking cessation modalities: comparing apples with oranges?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking treatment interventions and policies to promote their use: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost effectiveness of coronary heart disease prevention strategies in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The benefits of switching smoking cessation drugs to over-the-counter status.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

How much can business expect to profit from smoking cessation?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The cost-effectiveness of counseling smokers to quit.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The cost-effectiveness of the nicotine transdermal patch for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Development and implementation of a smoking cessation clinic in community pharmacy practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Results of a smoking cessation clinic in community pharmacy practice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of a smoking cessation program after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Methods to enhance smoking cessation after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Lifelong exposures and the potential for stroke prevention: the contribution of cigarette smoking, exercise, and body fat.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

New evidence for stroke prevention: scientific review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking cessation in heart failure: it is never too late

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-effectiveness of a hospital-based smoking cessation intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-Effectiveness Analysis of a Family Physician Delivered Smoking Cessation Program

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Pharmacoeconomic analysis of smoking-cessation interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Smoking cessation with and without assistance: a population-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The role of health plans in tobacco control.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Cigarette smoking and lifetime medical expenditures

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The use of simulation models for the surveillance, justification and understanding of tobacco control policies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Relationship between modifiable health risks and short-term health care charges.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The financial impact of changes in personal health practices

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Health care reform--more than cost containment and universal access

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Associations between health risk appraisal scores and employee medical claims costs in a manufacturing company

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs at the worksite: 1991-1993 update

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Comparing changes in health risk factors and medical costs over time

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Controlling tobacco use.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

The medical economics of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

Passive smoking and the risk of heart attack or coronary death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2803%2900077-X

7 January 2021

10.1016/S0033-0620(03)00077-X

Identifiers

DOI

1 reference

7 August 2017

1 reference